Disease-modifying antirheumatic drugs can reduce some cardiovascular risk in patients with rheumatoid arthritis, but questions remain if that's enough when statin use lags.

Related Keywords

Michaels Garshick , Los Angeles , Jont Giles , Langone Health , Sinai Inflammatory Arthritis Clinical Center At Cedars , Annual Cardiometabolic Risk , Inflammatory Conditions , Modifying Antirheumatic Drugs ,